Interaction of TFAP2A with the Ku70/80 complex is crucial for HIF ‐dependent activation of hypoxia‐inducible genes
The FEBS Journal · 2025-08 · 292 (16) · 4333-4352
DOI: 10.1111/febs.70025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 24.02.2025. Verfasst von Amalia Kanoura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Larissa, Greece. Hauptthemen laut MEDLINE: Transcription Factor AP-2, Hypoxia-Inducible Factor 1, alpha Subunit, Ku Autoantigen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation (H.F.R.I.).
Abstract (Originalsprache)
Hypoxia can be established under pathological conditions, such as cancer, due to the imbalance between oxygen supply and consumption. Hypoxia‐inducible transcription factor HIF‐1 mediates the physiological response to hypoxia but also regulates multiple steps of carcinogenesis. Despite its well‐defined oxygen‐dependent activation, many aspects of HIF‐1 transcriptional activity as well as interaction with chromatin remain elusive. We have recently shown that hypoxia triggered deSUMOylation of TFAP2A. To study the possible role of TFAP2A in the transcriptional response to hypoxia, we performed ChIP‐seq analysis. Our results have now shown that TFAP2A resides together with HIF‐1α on the promoters of a subset of hypoxia‐regulated genes, the mRNA expression of which is downregulated by silencing of TFAP2A . Interestingly, CRISPR‐mediated knockdown of TFAP2A expression under hypoxia decreased the occupancy of HIF‐1α on these promoters and affected chromatin accessibility. Mechanistically, we reveal that the Ku70/Ku80 protein complex interacts with deSUMOylated TFAP2A under hypoxia and participates in HIF‐dependent gene expression. Moreover, using stable expression of TFAP2A forms that either lack or constitutively carry a SUMO modification, we could show that SUMOylation affects binding of TFAP2A to chromatin. Overall, our data suggest that TFAP2A is an important co‐regulator of the HIF‐1‐dependent transcriptional response to hypoxia and SUMOylation fine‐tunes this regulation. As both TFAP2A and HIF‐1 play critical roles in cancer progression, a detailed characterization of their crosstalk could lead to novel therapeutic strategies for targeting and killing cancer cells in hypoxic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Larissa, Greece.
- Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
- Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Attica, Greece.
- Gerald Bronfman Department of Oncology, Faculty of Medicine, McGill University, Montreal, Canada.
ORCID-Profile: George Simos, Georgia Chachami
Förderung
- Hellenic Foundation for Research and Innovation (H.F.R.I.)
Zitieren
APA
Kanoura, A., Giakountis, A., Filippopoulou, C., Karagiota, A., Stamatakis, G., Samiotaki, M., Panayotou, G., Simos, G., & Chachami, G. (2025). Interaction of TFAP2A with the Ku70/80 complex is crucial for HIF ‐dependent activation of hypoxia‐inducible genes. The FEBS Journal, 292(16), 4333-4352. https://doi.org/10.1111/febs.70025
Vancouver
Kanoura A, Giakountis A, Filippopoulou C, Karagiota A, Stamatakis G, Samiotaki M, et al. Interaction of TFAP2A with the Ku70/80 complex is crucial for HIF ‐dependent activation of hypoxia‐inducible genes. The FEBS Journal. 2025;292(16):4333-4352. doi:10.1111/febs.70025
BibTeX
@article{Kanoura2025,
author = {Kanoura, Amalia and Giakountis, Antonis and Filippopoulou, Chrysa and Karagiota, Angeliki and Stamatakis, George and Samiotaki, Martina and Panayotou, George and Simos, George and Chachami, Georgia},
title = {Interaction of TFAP2A with the Ku70/80 complex is crucial for HIF ‐dependent activation of hypoxia‐inducible genes},
journal = {The FEBS Journal},
year = {2025},
volume = {292},
number = {16},
pages = {4333--4352},
doi = {10.1111/febs.70025}
}
EUVIMED